GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (NYSE:DHR) » Definitions » Cyclically Adjusted PB Ratio

Danaher (Danaher) Cyclically Adjusted PB Ratio : 4.59 (As of Apr. 27, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Danaher Cyclically Adjusted PB Ratio?

As of today (2024-04-27), Danaher's current share price is $246.58. Danaher's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $53.70. Danaher's Cyclically Adjusted PB Ratio for today is 4.59.

The historical rank and industry rank for Danaher's Cyclically Adjusted PB Ratio or its related term are showing as below:

DHR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.48   Med: 3.16   Max: 7.45
Current: 4.58

During the past years, Danaher's highest Cyclically Adjusted PB Ratio was 7.45. The lowest was 2.48. And the median was 3.16.

DHR's Cyclically Adjusted PB Ratio is ranked worse than
79.39% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.97 vs DHR: 4.58

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Danaher's adjusted book value per share data for the three months ended in Mar. 2024 was $72.160. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $53.70 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Danaher Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Danaher's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher Cyclically Adjusted PB Ratio Chart

Danaher Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.06 5.39 6.93 4.91 4.37

Danaher Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.50 4.17 4.20 4.37 4.65

Competitive Comparison of Danaher's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Danaher's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danaher's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Danaher's Cyclically Adjusted PB Ratio falls into.



Danaher Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Danaher's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=246.58/53.7
=4.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danaher's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Danaher's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=72.16/129.4194*129.4194
=72.160

Current CPI (Mar. 2024) = 129.4194.

Danaher Quarterly Data

Book Value per Share CPI Adj_Book
201406 33.848 100.560 43.562
201409 33.761 100.428 43.507
201412 33.193 99.070 43.362
201503 32.958 99.621 42.816
201506 35.262 100.684 45.326
201509 33.731 100.392 43.484
201512 34.494 99.792 44.735
201603 35.586 100.470 45.840
201606 36.271 101.688 46.162
201609 33.533 101.861 42.605
201612 33.231 101.863 42.221
201703 34.269 102.862 43.117
201706 35.397 103.349 44.326
201709 36.485 104.136 45.343
201712 37.838 104.011 47.081
201803 38.926 105.290 47.847
201806 38.891 106.317 47.342
201809 39.488 106.507 47.983
201812 40.221 105.998 49.108
201903 41.851 107.251 50.502
201906 42.662 108.070 51.090
201909 43.028 108.329 51.405
201912 41.224 108.420 49.208
202003 42.260 108.902 50.222
202006 46.523 108.767 55.357
202009 48.843 109.815 57.563
202012 51.333 109.897 60.452
202103 52.098 111.754 60.333
202106 55.321 114.631 62.458
202109 56.239 115.734 62.889
202112 58.600 117.630 64.473
202203 60.179 121.301 64.207
202206 61.762 125.017 63.937
202209 62.257 125.227 64.342
202212 66.475 125.222 68.703
202303 68.308 127.348 69.419
202306 70.058 128.729 70.434
202309 70.926 129.860 70.686
202312 72.357 129.419 72.357
202403 72.160 129.419 72.160

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Danaher  (NYSE:DHR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Danaher Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Danaher's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Danaher (Danaher) Business Description

Address
2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Executives
Jose-carlos Gutierrez-ramos officer: SVP, Chief Scientific Officer C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142
Linda Filler director 2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON DC 20037
Daniel Raskas officer: VP-Corporate Development 2099 PENNSYLVANIA AVENUE, NORTHWEST, WASHINGTON DC 20006
Teri List director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Joakim Weidemanis officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Walter G Lohr director DANAHER CORP, 2099 PENNSYLVANIA AVE NW 12TH FL, WASHINGTON DC 20006
Georgeann Couchara officer: SVP, Human Resources 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Raymond C Stevens director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Matthew Mcgrew officer: EVP & Chief Financial Officer 2200 PENNSYLVANIA AVENUE, NW, SUITE 800 W, WASHINGTON DC 20010
Jennifer Honeycutt officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Alan G Spoon director 1150 15TH ST NW, WASHINGTON DC 20071
Rainer Blair officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Feroz Dewan director C/O ARENA HOLDINGS MANAGEMENT LLC, 119 FIFTH AVENUE - 8TH FLOOR, NEW YORK NY 10003
Mitchell P Rales director, officer: Chairman of Exec. Committee 11790 GLEN ROAD, POTOMAC MD 20854
Brian W Ellis officer: Senior Vice President - GC 2200 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20037

Danaher (Danaher) Headlines

From GuruFocus

Q1 2023 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2021 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2023 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2020 Danaher Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024